Acumen Pharmaceuticals, Inc. (ABOS) CEO Daniel O'Connell on Q1 2022 Results - Earnings Call Transcript Published 17 May 2022 Full Article
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2022 Earnings Call Transcript Motley Fool 17 May 2022 ABOS earnings call for the period ending March 31, 2022.
Opiant Pharmaceuticals, Inc. (OPNT) CEO Dr. Roger Crystal on Q1 2022 Results - Earnings Call Transcript SeekingAlpha 14 May 2022